Óscar González‐Llano

Author

Universidad Autónoma de Nuevo León ORCID

Also Known As

O Gonzalez-Llano, O González-Llano, O. Gonzalez-LLano, O. Gonzalez-Llano, O. González-Llano, Oscar Gonz[aacute]lez-Llano, Oscar Gonzalez-Llano, Oscar Gonzalez‐Llano, Oscar González-Llano, Oscar Gonzàlez-Llano

137

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Universidad Autónoma de Nuevo León Clínica Ruiz Hospital Universitario Dr José Eleuterio Gonzalez National Institute of Genomic Medicine Universidad Autónoma de Zacatecas "Francisco García Salinas"

ÓG

About

Óscar González‐Llano is an author at Universidad Autónoma de Nuevo León specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	513
2	Cellular Therapies	6	6	316
3	Health Sciences	4	4	179
4	Blood Transplantation	3	3	182
5	Public Health	1	1	35

Óscar González‐Llano

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Results of an outpatient‐based stem cell allotransplant program using nonmyeloablative conditioning regimens Guillermo J. Ruíz‐Argüelles, David Gómez‐Almaguer, Alejandro Ruı́z-Argüelles, American Journal of Hematology Cell TherapyTransplant-related MortalityDeveloped Chronic GvhdImmunotherapyRegenerative Medicine	2001	89
Alemtuzumab for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease David Gómez‐Almaguer, Guillermo J. Ruíz‐Argüelles, Luz Tarín-Arzaga, Biology of Blood and Marrow Transplantation	2007	81
Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases David Gómez‐Almaguer, GJ Ruiz-Argüelles, Alejandro Ruı́z-Argüelles, Bone Marrow Transplantation Cell TherapyTransplantationMarrow TransplantationStem Cell TransplantationHematology	2000	74
Reduced-intensity stem cell transplantation in children and adolescents: The Mexican experience David Gómez‐Almaguer, Guillermo J. Ruíz‐Argüelles, Luz Tarín-Arzaga, Biology of Blood and Marrow Transplantation	2003	71
Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial Consuelo Mancías‐Guerra, Alma Rosa Marroquín-Escamilla, Óscar González‐Llano, Cytotherapy Regenerative MedicineCell TherapyBone Marrow FailureStem Cell TransplantationHematology	2014	58
Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy José Carlos Jaime‐Pérez, Laura Rodríguez‐Romo, Óscar González‐Llano, British Journal of Haematology ImmunologyPathologyMetronomic ChemotherapyImmunotherapyHematological Malignancy	2008	44
Circulating microRNA expression profile in B-cell acute lymphoblastic leukemia Claudia Maribel Luna-Aguirre, Fermín Mar‐Aguilar, Idalia Garza‐Veloz, Cancer Biomarkers	2015	44
Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia. Guillermo J. Ruíz‐Argüelles, David Gómez‐Almaguer, Briceida López-Martı́nez, PubMed Hematological MalignancyCell TherapyTransplantationMarrow TransplantationMedicine	2002	41
Relapse of childhood acute lymphoblastic leukemia and outcomes at a reference center in Latin America: organomegaly at diagnosis is a significant clinical predictor José Carlos Jaime‐Pérez, Mónica Andrea Pinzón-Uresti, Raúl Alberto Jiménez‐Castillo, Hematology	2017	39
Non-myeloablative stem cell transplantation in patients with relapsed acute lymphoblastic leukemia: results of a multicenter study Cesar Homero Gutiérrez‐Aguirre, David Gómez‐Almaguer, Olga Graciela Cantú‐Rodríguez, Bone Marrow Transplantation Hematological MalignancyCell TherapyTransplantationMarrow TransplantationMedicine	2007	36

Page 1